Skip to main content
AAN.com
Brief Communications
September 10, 2002
Letter to the Editor

Premorbid weight, body mass, and varsity athletics in ALS

September 10, 2002 issue
59 (5) 773-775

Abstract

Several famous athletes have been affected by ALS, and some epidemiologic studies have indicated that vigorous physical activity (heavy labor or athletics) is a risk factor for the disease. In a case-control study of 279 patients with motor neuron diseases and 152 with other neurologic diseases, the authors found that subjects with motor neuron diseases were more likely than controls to report they had always been slim or they had been varsity athletes. For slimness, the odds ratio (OR) was 2.21; 95% CI, 1.40 to 3.47. For varsity athletics, the OR was 1.70; CI, 1.04 to 2.76.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology . 1976; 26: 167–172.
2.
Granieri E, Carreras M, Tola R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964–1982. Neurology . 1988; 38: 1604–1608.
3.
Gregoire N, Serratrice G. Risk factors in amyotrophic lateral sclerosis: initial results apropos of 35 cases. Rev Neurol . 1991; 147: 706–713.
4.
Roelofs-Iverson RA, Mulder DW, Elveback LR, Kurland LT, Molgaard CA. ALS and heavy metals: a pilot case-control study. Neurology . 1984; 34: 393–395.
5.
Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology . 1980; 30: 453–462.
6.
Stevens J, Keil JE, Waid LR, Gazes PC. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol . 1990; 132: 1156–1163.
7.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. Obes Res 1998;6 (suppl) 2:51S–209S.
8.
Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses . 1991; 34: 144–148.
9.
Trueta J, Hodes R. Provoking and localising factors in poliomyelitis: an experimental study. Lancet . 1954; 1: 998–1001.
10.
Drory VE, Goltsman E, Goldman Reznik J, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci . 2001; 191: 133–137.
Letters to the Editor
28 May 2003
Reply to Letter to the Editor
Nikolaos Scarmeas
Lewis P. Rowland

We appreciate the interest of Dr. Vanacore in the possibly increased incidence of ALS in soccer players. How that might arise is not known. Branched chain amino acids might be toxic, but that possibility is still speculative, as are the effects of prolonged vigorous exercise and shared genetic susceptibility to both ALS and athleticism.

To prove a relationship between food and dietary supplements and ALS would require a study of the ingestion of nutritional or performance- enhancing substances in athletes engaged in many different sports. If any association with ALS were demonstrated, an investigation of the biological mechanisms could follow.

28 May 2003
Premorbid weight, body mass, and varsity athletics in ALS
Nicola Vanacore

I read with interest the case-control study by Scarmeas et al. reporting a significant association between amyotrophic lateral sclerosis (ALS) and a history of varsity athletes (OR = 1.70, CI95% 1.04-2.76). [1]

In an epidemiological study performed on 24,000 professional Italian soccer players the distribution of the causes of death of 350 Italian soccer players has been analyzed in terms of SPMR (Standardized Proportional Mortality Ratio).2 Mortality for motor neuron disease (ICD - IX Revision 335.2) between 1960 and 1996 was very high (SPMR = 11.6; eight observed vs 0.69 expected cases). Six of these eight cases (75%) were under the age of 59, the corresponding proportion in the Italian general population is 32.1%. Five other cases were registered after 1996. [2]

Some hypotheses have been proposed to explain the association between ALS and sport. In particular, physical trauma or limb injury and a vigorous physical activity have been investigated but the findings were conflicting.

Among the potential explanations it should be considered that subjects with genetic susceptibility who are chronic users of dietary supplements containing branched chain amino acid (BCAA) might bear a higher risk of ALS. The BCAA (leucine, isoleucine and valine) supplementation in athletes is frequently used to stimulate the muscular protein synthesis, to improve both mental and physical performances, and to accelerate the body's recovery after particulary intense and prolonged sport activities.

This hypothesis is supported by three different arguments : a) clinical and experimental evidences show that glutamatergic transmission is implicated in the pathogenesis of ALS; b) there is a relationship between cerebral metabolism of BCAA and glutamate: recently a putative model of brain leucine metabolism ("leucine-glutamate cycle") has been proposed [3]; c) after skeletal muscle, the brain is the organ with the highest activity of two key enzymes in the catabolism of BCAA: branched chain amino transferase (BCAT) and branched chain alfa ketoacid dehydrogenase (BCKD). [4]

Two mammalian BCATs exist : mitochondrial (BCATm) and cytosolic (BCATc) isoenzymes localized in the astroglia and neurons respectively. Moreover, the BCATc was found primarily in the pyramidal neurons. [5]

ALS is a complex disease, thus several factors, known or unknown, might increase the risk of experiencing this disease. Among susceptible athletes a high assumption of BCAA might play a key role.

References

1. Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 2002;59:773- 775.

2. Belli S. Causes of death of Italian soccer players. Epid Prev 2003;27:12.

3. Daikhin Y, Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 2000;130:1026S-1031S.

4. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998;68:72-81.

5. Hutson SM, Lieth E, LaNoue KF. Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 2001,131:846S-850S.

Information & Authors

Information

Published In

Neurology®
Volume 59Number 5September 10, 2002
Pages: 773-775
PubMed: 12221178

Publication History

Received: January 24, 2002
Accepted: May 16, 2002
Published online: September 10, 2002
Published in print: September 10, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

N. Scarmeas, MD
From the Department of Neurology (Drs. Scarmeas, Shih, Stern, Ottman, and Rowland) and the Eleanor and Lou Gehrig MDA/ALS Center, Neurological Institute of Columbia–Presbyterian Medical Center; and the Gertrude H. Sergievsky Center (Drs. Scarmeas, Stern, and Ottman), Columbia University College of Physicians and Surgeons, New York, NY.
T. Shih, MD
From the Department of Neurology (Drs. Scarmeas, Shih, Stern, Ottman, and Rowland) and the Eleanor and Lou Gehrig MDA/ALS Center, Neurological Institute of Columbia–Presbyterian Medical Center; and the Gertrude H. Sergievsky Center (Drs. Scarmeas, Stern, and Ottman), Columbia University College of Physicians and Surgeons, New York, NY.
Y. Stern, PhD
From the Department of Neurology (Drs. Scarmeas, Shih, Stern, Ottman, and Rowland) and the Eleanor and Lou Gehrig MDA/ALS Center, Neurological Institute of Columbia–Presbyterian Medical Center; and the Gertrude H. Sergievsky Center (Drs. Scarmeas, Stern, and Ottman), Columbia University College of Physicians and Surgeons, New York, NY.
R. Ottman, PhD
From the Department of Neurology (Drs. Scarmeas, Shih, Stern, Ottman, and Rowland) and the Eleanor and Lou Gehrig MDA/ALS Center, Neurological Institute of Columbia–Presbyterian Medical Center; and the Gertrude H. Sergievsky Center (Drs. Scarmeas, Stern, and Ottman), Columbia University College of Physicians and Surgeons, New York, NY.
L. P. Rowland, MD
From the Department of Neurology (Drs. Scarmeas, Shih, Stern, Ottman, and Rowland) and the Eleanor and Lou Gehrig MDA/ALS Center, Neurological Institute of Columbia–Presbyterian Medical Center; and the Gertrude H. Sergievsky Center (Drs. Scarmeas, Stern, and Ottman), Columbia University College of Physicians and Surgeons, New York, NY.

Notes

Address correspondence and reprint requests to Dr. Lewis P. Rowland, Neurological Institute, Box 147, 710 West 168th Street, New York, NY 10032; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression, Frontiers in Cell and Developmental Biology, 12, (2024).https://doi.org/10.3389/fcell.2024.1421566
    Crossref
  2. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions, Aging and disease, 15, 1, (74), (2024).https://doi.org/10.14336/AD.2023.0524
    Crossref
  3. Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis, Neurology, 103, 2, (2024)./doi/10.1212/WNL.0000000000209575
    Abstract
  4. Exercise training induces mild skeletal muscle adaptations without altering disease progression in a TDP-43 mouse model, Journal of Applied Physiology, 137, 3, (728-745), (2024).https://doi.org/10.1152/japplphysiol.00192.2023
    Crossref
  5. Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-72355-6
    Crossref
  6. Sex biology in amyotrophic lateral sclerosis, Ageing Research Reviews, 95, (102228), (2024).https://doi.org/10.1016/j.arr.2024.102228
    Crossref
  7. Therapie bei ALS, Amyotrophe Lateralsklerose, (33-58), (2024).https://doi.org/10.1007/978-3-662-68832-8_6
    Crossref
  8. Association Between Early‐Life and Premorbid Measurements of Body Composition and Risk of Motor Neuron Disease: A Prospective Cohort Study in the UK Biobank , Annals of Neurology, (2024).https://doi.org/10.1002/ana.27109
    Crossref
  9. Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives, Cells, 12, 13, (1763), (2023).https://doi.org/10.3390/cells12131763
    Crossref
  10. Body mass index and survival from amyotrophic lateral sclerosis, Neurology Clinical Practice, 8, 5, (437-444), (2023)./doi/10.1212/CPJ.0000000000000521
    Abstract
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share